Bilateral globus pallidus stimulation for Huntington's disease

Area of Science:

• Neuroscience
• Neurology
• Neurosurgery

Background:

• Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms.
• Severe chorea, an involuntary hyperkinetic movement disorder, significantly impacts the quality of life in HD patients.
• Deep brain stimulation (DBS) is an emerging therapeutic option for managing motor symptoms in advanced neurological conditions.

Purpose of the Study:

• To evaluate the efficacy of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) in a patient with severe chorea due to Huntington's disease (HD).
• To investigate the effects of different stimulation frequencies (40 Hz and 130 Hz) on chorea and bradykinesia.
• To assess the impact of GPi DBS on regional cerebral blood flow (rCBF) in motor-related brain areas.

Main Methods:

• Bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) was surgically implanted.
• The patient received continuous stimulation at two different frequencies: 40 Hz and 130 Hz.
• Motor symptoms (chorea and bradykinesia) were assessed during stimulation.
• [15O] H2O positron emission tomography (PET) was used to measure regional cerebral blood flow (rCBF).

Main Results:

• Both 40 Hz and 130 Hz stimulation frequencies demonstrated improvement in chorea.
• Bradykinesia was slightly worsened at 130 Hz stimulation, while 40 Hz stimulation had minimal effect.
• Positron emission tomography revealed increased rCBF in motor decision-making and execution areas, particularly evident at 40 Hz stimulation.

Conclusions:

• GPi DBS is a potential treatment for severe chorea in Huntington's disease.
• Adjusting stimulation parameters, specifically frequency, may allow for optimization of motor response in HD.
• Targeted GPi DBS may improve chorea while mitigating the risk of aggravating bradykinesia, suggesting a potential for tailored therapeutic strategies.